Valuation Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 90.78 USD | +1.18% |
|
92.64 | +2.04% |
Company Valuation: Edwards Lifesciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,883 | 46,128 | 46,246 | 43,663 | 49,471 | 52,271 | - | - |
| Change | - | -42.97% | 0.25% | -5.58% | 13.3% | 5.66% | - | - |
| Enterprise Value (EV) 1 | 80,616 | 45,956 | 45,198 | 40,285 | 45,843 | 48,789 | 47,199 | 45,356 |
| Change | - | -42.99% | -1.65% | -10.87% | 13.8% | 6.43% | -3.26% | -3.9% |
| P/E | 54.4x | 30.6x | 33.2x | 10.6x | 46.6x | 32.4x | 27.7x | 24.7x |
| PBR | 13.9x | 7.82x | 6.99x | 4.36x | 4.79x | 4.78x | 4.34x | 4.15x |
| PEG | - | 12.14x | -5.79x | 0x | -0.6x | 0.6x | 1.7x | 2x |
| Capitalization / Revenue | 15.5x | 8.57x | 7.7x | 8.03x | 8.15x | 7.75x | 7.05x | 6.42x |
| EV / Revenue | 15.4x | 8.54x | 7.53x | 7.41x | 7.56x | 7.23x | 6.37x | 5.57x |
| EV / EBITDA | 46.6x | 23.7x | 24.1x | 24.1x | 25.5x | 23x | 19.9x | 16.9x |
| EV / EBIT | 50.6x | 25.6x | 26.1x | 26.6x | 27.9x | 24.9x | 21.5x | 18.4x |
| EV / FCF | 57.3x | 47.2x | 47.9x | 139x | 34.3x | 35.8x | 27.9x | 23.5x |
| FCF Yield | 1.74% | 2.12% | 2.09% | 0.72% | 2.91% | 2.79% | 3.59% | 4.26% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.38 | 2.44 | 2.3 | 6.97 | 1.83 | 2.804 | 3.273 | 3.671 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 5,232 | 5,382 | 6,005 | 5,440 | 6,068 | 6,748 | 7,411 | 8,146 |
| EBITDA 1 | 1,729 | 1,936 | 1,879 | 1,670 | 1,800 | 2,122 | 2,372 | 2,682 |
| EBIT 1 | 1,594 | 1,796 | 1,734 | 1,514 | 1,644 | 1,959 | 2,195 | 2,466 |
| Net income 1 | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 | 1,624 | 1,891 | 2,115 |
| Net Debt 1 | -267 | -172.7 | -1,048 | -3,378 | -3,628 | -3,482 | -5,073 | -6,915 |
| Reference price 2 | 129.55 | 74.61 | 76.25 | 74.03 | 85.25 | 90.78 | 90.78 | 90.78 |
| Nbr of stocks (in thousands) | 624,334 | 618,260 | 606,500 | 589,800 | 580,300 | 575,800 | - | - |
| Announcement Date | 1/26/22 | 1/31/23 | 2/6/24 | 2/11/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.37x | 7.23x | 22.99x | -.--% | 52.27B | ||
| 25.69x | 4.64x | 17.87x | 0.36% | 191B | ||
| 44.44x | 11.64x | 26.04x | -.--% | 143B | ||
| 31.26x | - | - | 0.73% | 139B | ||
| 16.25x | 3.38x | 10.89x | -.--% | 65.74B | ||
| 18.03x | 2.09x | 10.7x | 2.92% | 43.55B | ||
| 26.42x | 5.27x | 18.2x | 0.75% | 38.41B | ||
| 45.38x | 6.36x | 19.59x | -.--% | 36.76B | ||
| 14.66x | 1.64x | 9.18x | 0.24% | 29.91B | ||
| 18.9x | 4.97x | 12.82x | 1.21% | 28.93B | ||
| Average | 27.34x | 5.24x | 16.48x | 0.62% | 76.84B | |
| Weighted average by Cap. | 29.70x | 6.15x | 18.41x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EW Stock
- Valuation Edwards Lifesciences Corporation
Select your edition
All financial news and data tailored to specific country editions
















